Published in Kidney Int on May 29, 2013
Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med (2016) 5.14
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81
Foundations and principles of the Canadian living donor paired exchange program. Can J Kidney Health Dis (2014) 0.79
Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. Pediatr Nephrol (2016) 0.75
Past, present and future of kidney paired donation transplantation in India. World J Transplant (2017) 0.75
Desensitization: Overcoming the Immunologic Barriers to Transplantation. J Immunol Res (2017) 0.75
Relationship between viremia/viral infection, alloimmunity and nutritional parameters in the first year after pediatric kidney transplantation. Am J Transplant (2016) 0.75
Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients. Pediatr Transplant (2017) 0.75
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant (2006) 2.37
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation (2008) 1.84
Kidney paired donation and optimizing the use of live donor organs. JAMA (2005) 1.82
Cold ischemia time and allograft outcomes in live donor renal transplantation: is live donor organ transport feasible? Am J Transplant (2007) 1.81
A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med (2009) 1.81
The roles of dominos and nonsimultaneous chains in kidney paired donation. Am J Transplant (2009) 1.61
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation (2002) 1.58
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant (2003) 1.54
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant (2007) 1.49
Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant (2003) 1.29
Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant (2008) 1.27
Positive cross-match living donor kidney transplantation: longer-term outcomes. Am J Transplant (2009) 1.26
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation (2009) 1.23
Using real data for a virtual crossmatch. Hum Immunol (2009) 1.23
Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation (2003) 1.10
Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant (2004) 1.05
Chain transplantation: initial experience of a large multicenter program. Am J Transplant (2012) 1.02
Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant (2011) 0.98
Single-center kidney paired donation: the Methodist San Antonio experience. Am J Transplant (2012) 0.97
Paired kidney donation by shipment of living donor kidneys. Clin Transplant (2007) 0.92
Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG. Am J Transplant (2006) 0.92
Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept. Am J Transplant (2009) 0.89
Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody. Transplantation (2007) 0.86
Successful three-way kidney paired donation with cross-country live donor allograft transport. Am J Transplant (2008) 0.86
Analysis of HLA-ABC locus-specific transcription in normal tissues. Immunogenetics (2010) 0.86
Kidney paired donation--the next step. N Engl J Med (2011) 0.82
High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation. Transplantation (2012) 0.81
The National Kidney Registry: transplant chains--beyond paired kidney donation. Clin Transpl (2009) 0.77
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med (1995) 5.41
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis (2005) 2.47
The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38
Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24
Sirolimus-associated pulmonary toxicity. Transplantation (2004) 2.15
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. Hum Immunol (2007) 2.08
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol (2003) 1.85
Emphysema: effect of reconstruction algorithm on CT imaging measures. Radiology (2004) 1.81
Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation (1998) 1.78
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol (2008) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
The hyperfiltration hypothesis in human renal transplantation. Transplantation (1994) 1.63
Living unrelated donor kidney transplantation. Kidney Int (2000) 1.61
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Structure of murine Ia antigens: partial NH2-terminal amino acid sequences of products of the I-E or I-C subregion. Proc Natl Acad Sci U S A (1977) 1.56
Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum (2006) 1.55
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant (2003) 1.54
Kidney transplant chains amplify benefit of nondirected donors. JAMA Surg (2013) 1.52
Waiting time or wasted time? The case for using time on dialysis to determine waiting time in the allocation of cadaveric kidneys. Am J Transplant (2002) 1.50
Renal graft outcome after combined liver and kidney transplantation in children: UCLA and UNOS experience. Pediatr Transplant (2010) 1.46
Computer-aided lung nodule detection in CT: results of large-scale observer test. Acad Radiol (2005) 1.45
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
Optimizing HLA matching in a highly sensitized pediatric patient using ABO-incompatible and paired exchange kidney transplantation. Pediatr Nephrol (2015) 1.42
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy. J Gene Med (2010) 1.38
Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg (2006) 1.36
Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol (2008) 1.33
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol (2008) 1.31
HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation (2006) 1.29
A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med (2002) 1.28
Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol (2007) 1.26
Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis (2008) 1.25
Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg (2006) 1.20
New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am (2007) 1.19
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med (2000) 1.18
Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology (2002) 1.18
The effect of race and ethnicity on kidney allograft outcome. Clin Transpl (1995) 1.18
Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol (2004) 1.16
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant (2010) 1.14
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther (2013) 1.14
Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol (2006) 1.14
Chemical characterization of products of the H-2 complex. Cold Spring Harb Symp Quant Biol (1977) 1.11
Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proc Natl Acad Sci U S A (2011) 1.11
Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am J Transplant (2009) 1.10
Peptide map analyses of murine Ia antigens of the I-E subregion using HPLC. Nature (1979) 1.10
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. Mol Ther (2009) 1.10
Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation (2000) 1.09
HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol (2004) 1.09
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Obesity and its impact on transplantation and alloimmunity. Transplantation (2013) 1.08
RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol (2007) 1.08
Evaluation of adult kidney transplant candidates. Am J Kidney Dis (2007) 1.07
Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol (2002) 1.07
Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics (2006) 1.07
Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant (2009) 1.06
HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration. Sci Signal (2010) 1.06
Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation (2005) 1.05
The UNOS Scientific Renal Transplant Registry. Clin Transpl (1999) 1.04
HLA-B maternal-fetal genotype matching increases risk of schizophrenia. Am J Hum Genet (2006) 1.04
Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res (2009) 1.02
Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy. Mol Ther (2012) 1.02
Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardiac transplant rejection? Cardiovasc Pathol (2008) 1.02
HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs. J Immunol (2013) 1.02
Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation (1998) 1.01
C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant (2005) 1.01
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clin Cancer Res (2014) 1.01
Evaluation of gene promoters for liver expression by hydrodynamic gene transfer. J Surg Res (2008) 1.00
Partial N-terminal amino acid sequence analyses and comparative tryptic peptide maps of murine Ia molecules encoded by the I-A subregion. Eur J Immunol (1979) 1.00
Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS database. Transplantation (2008) 0.99
HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation (2011) 0.99
CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation (2006) 0.98
Risk rate and long-term kidney transplant survival. Clin Transpl (1996) 0.98
Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant (2009) 0.97
Should pediatric patients wait for HLA-DR-matched renal transplants? Am J Transplant (2008) 0.97
Reproducibility of lung and lobar volume measurements using computed tomography. Acad Radiol (2009) 0.97
Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation (2006) 0.96
Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry. Pediatr Transplant (2001) 0.96
Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl (1997) 0.95
Small airways response to naturalistic cat allergen exposure in subjects with asthma. J Allergy Clin Immunol (2006) 0.95
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. Mol Genet Metab (2013) 0.94